Frederik C. Kruger

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

Kris V. Kowdley, Christopher L. Bowlus, Cynthia Levy et al. · New England Journal of Medicine · 2023 · 263 citations

Medicine, Pharmacology, Pharmacotherapy +17

APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH.

Frederik C. Kruger, C Daniels, Martin Kidd et al. · PubMed · 2011 · 159 citations

Medicine, Internal Medicine, Pathology +17

Non-alcoholic fatty liver disease (NAFLD) in the Western Cape: A descriptive anaylsis

Frederik C. Kruger, C Daniels, Martin Kidd et al. · South African Medical Journal · 2010 · 37 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Safety, Immunogenicity and Clinical Phase I-II Results of TNFα-Kinoid Immunotherapeutic in Crohn's Disease Patients

Pierre Vandepapelière, Francois Malan, Gerhard Rogler et al. · Gastroenterology · 2011 · 15 citations

Life Sciences, Immunology, Clinical Immunology +15